• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同框 SCL6A3 纯合变异导致一个近亲结婚家族的多巴胺转运体缺陷综合征。

Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.

机构信息

Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Myelin Disorders Clinic, Pediatric Neurology Division, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Ann Hum Genet. 2020 Jul;84(4):315-323. doi: 10.1111/ahg.12378. Epub 2020 Feb 20.

DOI:10.1111/ahg.12378
PMID:32077500
Abstract

The human dopamine transporter (hDAT) participates in dopamine homeostasis by clearing dopamine from the extracellular space using secondary active transport. Dysregulation of hDAT has been reported to be associated with different neuropsychiatric disorders. Dopamine transporter deficiency syndrome (DTDS) is a complex disease caused by defects in dopamine uptake within the synaptic cleft and patients manifest parkinsonian features. The extracellular loops are crucial for DAT activity and defects in these regions disturb dopamine transport. In the present study, a 3.5-year-old female in a consanguineous Iranian family with an initial diagnosis of gait imbalance and speech delay has been identified. We utilized whole-exome sequencing (WES) to identify the possible genetic defect(s). WES identified a novel homozygous in-frame indel variant, c.1139_1150del; p.(Gly380_Lys384delinsGlu), in the SLC6A3 gene (NM_001044.4), as the most likely disease-susceptibility variant. This variant is located in extracellular loop 4 (EL4) of the DAT protein. Our study highlights the role of extracellular loops and shows the EL4 of hDAT as a critical region for the protein activity. The identified variant in the EL4 region of DAT is predicted to compromise DAT function and may lead to DTDS in this case. However, complementary studies are required to confirm.

摘要

人类多巴胺转运体(hDAT)通过次级主动转运从细胞外间隙清除多巴胺,参与多巴胺的动态平衡。hDAT 的失调与多种神经精神疾病有关。多巴胺转运体缺陷综合征(DTDS)是一种复杂的疾病,由突触间隙内多巴胺摄取缺陷引起,患者表现出帕金森病特征。细胞外环对于 DAT 的活性至关重要,这些区域的缺陷会干扰多巴胺的转运。在本研究中,我们鉴定了一名来自伊朗有血缘关系家庭的 3.5 岁女性,她最初被诊断为步态失衡和言语迟缓。我们利用全外显子组测序(WES)来鉴定可能的遗传缺陷。WES 发现了 SLC6A3 基因(NM_001044.4)中一个新的纯合框内缺失突变 c.1139_1150del;p.(Gly380_Lys384delinsGlu),这是最有可能导致疾病的变异。该变异位于 DAT 蛋白的细胞外环 4(EL4)中。我们的研究强调了细胞外环的作用,并表明 hDAT 的 EL4 是蛋白质活性的关键区域。在 DAT 的 EL4 区域中鉴定出的变异预计会损害 DAT 的功能,并可能导致该病例中的 DTDS。然而,需要进一步的互补研究来证实。

相似文献

1
Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.同框 SCL6A3 纯合变异导致一个近亲结婚家族的多巴胺转运体缺陷综合征。
Ann Hum Genet. 2020 Jul;84(4):315-323. doi: 10.1111/ahg.12378. Epub 2020 Feb 20.
2
Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.由与婴儿帕金森病-肌张力障碍相关的突变揭示的运动和精神损害及治疗意义。
Elife. 2021 May 18;10:e68039. doi: 10.7554/eLife.68039.
3
Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.鉴定帕金森病和神经精神疾病患者多巴胺转运体变异体的显性负效应。
JCI Insight. 2021 Sep 22;6(18):e151496. doi: 10.1172/jci.insight.151496.
4
Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.编码多巴胺转运体的基因中的纯合功能丧失突变与婴儿帕金森-肌张力障碍有关。
J Clin Invest. 2009 Jun;119(6):1595-603. doi: 10.1172/JCI39060. Epub 2009 May 26.
5
SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.在两名自闭症先证者中发现的SLC6A3编码变体Ala559Val改变了多巴胺转运体的功能和运输。
Transl Psychiatry. 2014 Oct 14;4(10):e464. doi: 10.1038/tp.2014.90.
6
Pharmacochaperoning in a model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism.模型系统中的药物伴侣疗法挽救了与婴儿期/青少年期帕金森病相关的人类多巴胺转运体变体。
J Biol Chem. 2017 Nov 24;292(47):19250-19265. doi: 10.1074/jbc.M117.797092. Epub 2017 Sep 29.
7
Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.多巴胺转运体缺陷综合征:从婴儿期到成年期的表型谱。
Brain. 2014 Apr;137(Pt 4):1107-19. doi: 10.1093/brain/awu022. Epub 2014 Mar 10.
8
A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome.一种用于研究多巴胺转运体缺乏综合征的秀丽隐杆线虫模型。
Eur J Neurosci. 2017 Jan;45(1):207-214. doi: 10.1111/ejn.13366. Epub 2016 Sep 2.
9
De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.多巴胺转运体基因的新生突变将多巴胺功能障碍与自闭症谱系障碍联系起来。
Mol Psychiatry. 2013 Dec;18(12):1315-23. doi: 10.1038/mp.2013.102. Epub 2013 Aug 27.
10
A novel homozygous PTH1R variant identified through whole-exome sequencing further expands the clinical spectrum of primary failure of tooth eruption in a consanguineous Saudi family.通过全外显子组测序鉴定出的一种新型纯合甲状旁腺激素1型受体(PTH1R)变异,进一步扩展了一个沙特近亲家族中牙齿萌出原发性失败的临床谱。
Arch Oral Biol. 2016 Jul;67:28-33. doi: 10.1016/j.archoralbio.2016.03.012. Epub 2016 Mar 23.

引用本文的文献

1
Potential role of SLC6A3 in neurodevelopmental impairments associated with corpus callosum abnormalities: insights from CNV analysis and clinical phenotyping.溶质载体家族6成员3(SLC6A3)在与胼胝体异常相关的神经发育障碍中的潜在作用:来自拷贝数变异分析和临床表型分析的见解
Mol Cytogenet. 2025 Aug 22;18(1):21. doi: 10.1186/s13039-025-00725-4.
2
Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches.多巴胺转运体缺陷综合征(DTDS):扩展临床表型和精准医学方法。
Cells. 2023 Jun 28;12(13):1737. doi: 10.3390/cells12131737.
3
The dopamine transporter gene SLC6A3: multidisease risks.
多巴胺转运体基因 SLC6A3:多种疾病风险。
Mol Psychiatry. 2022 Feb;27(2):1031-1046. doi: 10.1038/s41380-021-01341-5. Epub 2021 Oct 14.
4
Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.鉴定帕金森病和神经精神疾病患者多巴胺转运体变异体的显性负效应。
JCI Insight. 2021 Sep 22;6(18):e151496. doi: 10.1172/jci.insight.151496.
5
Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism.基因治疗可恢复多巴胺转运体的表达,并改善 iPSC 和婴儿帕金森病小鼠模型的病理。
Sci Transl Med. 2021 May 19;13(594). doi: 10.1126/scitranslmed.aaw1564.
6
A novel deletion variant in CLN3 with highly variable expressivity is responsible for juvenile neuronal ceroid lipofuscinoses.一个具有高度表现变异性的 CLN3 新型缺失变异体是导致少年神经元蜡样脂褐质沉积症的原因。
Acta Neurol Belg. 2021 Jun;121(3):737-748. doi: 10.1007/s13760-021-01655-9. Epub 2021 Mar 30.
7
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.疾病变异对神经递质转运体的功能和生化影响:特别强调折叠和运输缺陷。
Pharmacol Ther. 2021 Jun;222:107785. doi: 10.1016/j.pharmthera.2020.107785. Epub 2020 Dec 10.
8
Biallelic in-frame deletion in TRAPPC4 in a family with developmental delay and cerebellar atrophy.一个患有发育迟缓及小脑萎缩的家族中,TRAPPC4基因的双等位基因框内缺失。
Brain. 2020 Oct 1;143(10):e83. doi: 10.1093/brain/awaa256.